A dynamic stochastic model for colon and rectum cancer is developed to obtain the optimal ages to perform colonoscopies. The currently recommended guideline for colonoscopy is to test at ages 50, 60, 70, 80 and 90. Our Monte Carlo simulation yields a cost/life-year saved of $54,919.62 for the official policy. We ask the following: if we could reallocate the 5 tests between the ages of 50 and 90, which ages for testing would give the lowest cost/life-year saved? Of the 91,309 possible policies 43,026, or 47%, have a better cost per life-year saved than the currently recommended guidelines. The policy with the lowest cost is to test at the ages of 64, 71, 73, 79, 85 with a cost of $38,081.37 per life-year saved. An improvement of 30% in the cost/life-year saved. The framework developed in this paper can be further used to evaluate the cost effectiveness of current guidelines for other cancers. The policies can be personalized by sex and race to have better cost- effectiveness ratios. Finally, guidelines can be developed to equate cost per life-year saved across different cancers.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
A dynamic stochastic model for colon and rectum cancer is developed to obtain the optimal ages to perform colonoscopies. The currently recommended guideline for colonoscopy is to test at ages 50, 60, 70, 80 and 90. Our Monte Carlo simulation yields a cost/life-year saved of $54,919.62 for the official policy. We ask the following: if we could reallocate the 5 tests between the ages of 50 and 90, which ages for testing would give the lowest cost/life-year saved? Of the 91,309 possible policies 43,026, or 47%, have a better cost per life-year saved than the currently recommended guidelines. The policy with the lowest cost is to test at the ages of 64, 71, 73, 79, 85 with a cost of $38,081.37 per life-year saved. An improvement of 30% in the cost/life-year saved. The framework developed in this paper can be further used to evaluate the cost effectiveness of current guidelines for other cancers. The policies can be personalized by sex and race to have better cost- effectiveness ratios. Finally, guidelines can be developed to equate cost per life-year saved across different cancers.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -A dynamic stochastic model for colon and rectum cancer is developed to obtain the optimal ages to perform colonoscopies. The currently recommended guideline for colonoscopy is to test at ages 50, 60, 70, 80 and 90. Our Monte Carlo simulation yields a cost/life-year saved of $54,919.62 for the official policy. We ask the following: if we could reallocate the 5 tests between the ages of 50 and 90, which ages for testing would give the lowest cost/life-year saved Of the 91,309 possible policies 43,026, or 47%, have a better cost per life-year saved than the currently recommended guidelines. The policy with the lowest cost is to test at the ages of 64, 71, 73, 79, 85 with a cost of $38,081.37 per life-year saved. An improvement of 30% in the cost/life-year saved. The framework developed in this paper can be further used to evaluate the cost effectiveness of current guidelines for other cancers. The policies can be personalized by sex and race to have better cost-effectiveness ratios. Finally, guidelines can be developed to equate cost per life-year saved across different cancers. 64 pp. Englisch. N° de réf. du vendeur 9783838300894
Quantité disponible : 2 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A dynamic stochastic model for colon and rectum cancer is developed to obtain the optimal ages to perform colonoscopies. The currently recommended guideline for colonoscopy is to test at ages 50, 60, 70, 80 and 90. Our Monte Carlo simulation yields a cost/life-year saved of $54,919.62 for the official policy. We ask the following: if we could reallocate the 5 tests between the ages of 50 and 90, which ages for testing would give the lowest cost/life-year saved Of the 91,309 possible policies 43,026, or 47%, have a better cost per life-year saved than the currently recommended guidelines. The policy with the lowest cost is to test at the ages of 64, 71, 73, 79, 85 with a cost of $38,081.37 per life-year saved. An improvement of 30% in the cost/life-year saved. The framework developed in this paper can be further used to evaluate the cost effectiveness of current guidelines for other cancers. The policies can be personalized by sex and race to have better cost-effectiveness ratios. Finally, guidelines can be developed to equate cost per life-year saved across different cancers. N° de réf. du vendeur 9783838300894
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Gonzalez JavierHe obtained his Ph.D. in economics from the University of Pennsylvania, specializing in computer economics. Previously he received a masters and bachelor in economics from the U. of British Columbia. He has been aw. N° de réf. du vendeur 5410837
Quantité disponible : Plus de 20 disponibles
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -A dynamic stochastic model for colon and rectum cancer is developed to obtain the optimal ages to perform colonoscopies. The currently recommended guideline for colonoscopy is to test at ages 50, 60, 70, 80 and 90. Our Monte Carlo simulation yields a cost/life-year saved of $54,919.62 for the official policy. We ask the following: if we could reallocate the 5 tests between the ages of 50 and 90, which ages for testing would give the lowest cost/life-year saved Of the 91,309 possible policies 43,026, or 47%, have a better cost per life-year saved than the currently recommended guidelines. The policy with the lowest cost is to test at the ages of 64, 71, 73, 79, 85 with a cost of $38,081.37 per life-year saved. An improvement of 30% in the cost/life-year saved. The framework developed in this paper can be further used to evaluate the cost effectiveness of current guidelines for other cancers. The policies can be personalized by sex and race to have better cost- effectiveness ratios. Finally, guidelines can be developed to equate cost per life-year saved across different cancers.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 64 pp. Englisch. N° de réf. du vendeur 9783838300894
Quantité disponible : 1 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
paperback. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA80038383008906
Quantité disponible : 1 disponible(s)